Who owns AKOYA BIOSCIENCES INC?
- Ticker: AKYA
- CUSIP Number: 00974h104
Tip: Access positions for across all investors
Analyze quarterly positions in Akoya Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Akoya Biosciences stock
Who bought or sold AKOYA BIOSCIENCES INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Blue Water Life Science Advisors | 4.7M | $23M | 0% | Dec 2023 |
|
Vanguard Group | 1.4M | $6.9M | 4% | Dec 2023 |
|
Board of Trustees of The Leland Stanford Junior University | 620k | $3.0M | 0% | Dec 2023 |
|
Bp Wealth Management | 515k | $2.5M | 0% | Dec 2023 |
|
Peddock Capital Advisors | 291k | $1.4M | 546% | Dec 2023 |
|
Charles Schwab Investment Management | 205k | $1000k | 34% | Dec 2023 |
|
Millennium Management | 157k | $768k | -71% | Dec 2023 |
|
Schonfeld Strategic Advisors | 156k | $760k | 20% | Dec 2023 |
|
Osterweis Capital Management | 126k | $616k | 0% | Dec 2023 |
|
Kent Lake Capital | 117k | $570k | -84% | Dec 2023 |
|
Squarepoint Ops | 97k | $473k | -24% | Dec 2023 |
|
Bank of New York Mellon | 85k | $414k | -36% | Dec 2023 |
|
ZWJ Investment Counsel | 45k | $221k | 0% | Dec 2023 |
|
Barclays | 33k | $163k | 512% | Dec 2023 |
|
Rhumbline Advisers | 33k | $161k | 37% | Dec 2023 |
|
Cubist Systematic Strategies | 33k | $160k | -33% | Dec 2023 |
|
HighTower Advisors | 27k | $133k | -12% | Dec 2023 |
|
Alliancebernstein | 27k | $133k | 0% | Dec 2023 |
|
UBS Group | 25k | $124k | 151% | Dec 2023 |
|
Citadel Advisors | 23k | $113k | -76% | Dec 2023 |
|
Jane Street | 22k | $108k | 100% | Dec 2023 |
|
Bank of America Corporation | 22k | $107k | 52% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 22k | $106k | 2472% | Dec 2023 |
|
Dimensional Fund Advisors | 18k | $90k | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 15k | $72k | 0% | Dec 2023 |
|
State of Wisconsin Investment Board | 15k | $71k | 100% | Dec 2023 |
|
New York State Common Retirement Fund | 12k | $58k | 0% | Dec 2023 |
|
American International | 12k | $56k | 3% | Dec 2023 |
|
Stifel Financial | 11k | $52k | 100% | Dec 2023 |
|
Goldman Sachs Group | 10k | $49k | -47% | Dec 2023 |
|
Royal Bank of Canada | 8.1k | $40k | 155% | Dec 2023 |
|
Point72 Middle East FZE | 6.4k | $31k | 100% | Dec 2023 |
|
NISA Investment Advisors | 6.1k | $30k | 10169% | Dec 2023 |
|
Wells Fargo & Company | 6.0k | $29k | 35% | Dec 2023 |
|
Citigroup | 3.4k | $17k | 17889% | Dec 2023 |
|
Legal & General Group | 2.7k | $13k | 21% | Dec 2023 |
|
Amalgamated Bank | 2.4k | $12k | -5% | Dec 2023 |
|
Summit Investment Advisors | 1.2k | $5.9k | 0% | Dec 2023 |
|
Steward Partners Investment Advisory | 400.00 | $2.0k | 100% | Dec 2023 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 200.00 | $0 | 0% | Dec 2023 |
|
Capital Advisors | 59.00 | $0 | 0% | Mar 2024 |
|
Glassman Wealth Services | 50.00 | $244.000000 | 28% | Dec 2023 |
|
Pnc Financial Services | 17.00 | $83.000800 | 100% | Dec 2023 |
|
Farther Finance Advisors | 4.00 | $20.000000 | 100% | Dec 2023 |
|
Who sold out of Akoya Biosciences?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Kennedy Capital Management | Sep 2023 | 298k | $1.4M |
Jacobs Levy Equity Management | Sep 2023 | 56k | $260k |
Weiss Multi-strategy Advisers | Dec 2023 | 51k | $249k |
Trexquant Investment | Sep 2023 | 50k | $234k |
Regions Bank | Sep 2023 | 13k | $60k |